Extra-articular manifestations in psoriatic arthritis patients

Clinical Rheumatology

Volumn 34, Issue 4, 2015, Pages 745-753

  Peluso, Rosario ^a   Iervolino, Salvatore ^b   Vitiello, Maria ^a   Bruner, Vincenzo ^a   Lupoli, Gelsy ^a   Di Minno, Matteo Nicola Dario ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b IRCCS   (Italy)

Author keywords

Extra articular manifestation; Psoriasis; Psoriatic arthritis

Indexed keywords

ADULT; ARTHRITIS, PSORIATIC; CARDIOVASCULAR DISEASES; EYE DISEASES; FEMALE; HUMAN; INFLAMMATION; INTESTINAL DISEASES; LUNG DISEASES; MALE; MIDDLE AGED; PREVALENCE; RETROSPECTIVE STUDY; RHEUMATIC DISEASES; SEX DIFFERENCE; SKIN DISEASES; TREATMENT OUTCOME; UROLOGIC DISEASES;

ADULT; ARTHRITIS, PSORIATIC; CARDIOVASCULAR DISEASES; EYE DISEASES; FEMALE; HUMANS; INFLAMMATION; INTESTINAL DISEASES; LUNG DISEASES; MALE; MIDDLE AGED; PREVALENCE; RETROSPECTIVE STUDIES; RHEUMATIC DISEASES; SEX FACTORS; SKIN DISEASES; TREATMENT OUTCOME; UROLOGIC DISEASES;

EID: 84927802334     PISSN: 07703198     EISSN: 14349949     Source Type: Journal    
DOI: 10.1007/s10067-014-2652-9     Document Type: Article

References (50)

1. Scarpa R, Peluso R, Atteno M (2007) Clinical presentation of psoriatic arthritis. Reumatismo 59(suppl1):49–51
2. Helliwell PS (2009) Established psoriatic arthritis: clinical aspects. J Rheumatol 36(suppl83):21–3
3. Scarpa R, Cosentini E, Manguso F, Oriente A, Peluso R, Atteno M, Ayala F, D’Arienzo A, Oriente P (2003) Clinical and genetic aspects of psoriatic arthritis “sine psoriasis”. J Rheumatol 30(12):2638–40
4. Scarpa R, Cuocolo A, Peluso R, Atteno M, Gisonni P, Iervolino S, Di Minno MN, Nicolai E, Salvatore M, del Puente A (2008) Early psoriatic arthritis: the clinical spectrum. J Rheumatol 35(1):137–41
5. Scarpa R, Atteno M, Costa L, Peluso R, Iervolino S, Caso F, Del Puente A (2009) Early psoriatic arthritis. J Rheumatol Suppl 83:26–7
6. Wright V (1978) Seronegative polyarthritis: a unified concept. Arthritis Rheum 21:619–33
7. Gladman DD (1998) Clinical aspects of the spondyloarthropathies. Am J Med Sci 316(4):234–8
8. Taylor W, Gladman D, Helliwell P, Marchesoni A, Mease P, Mielants H, CASPAR Study Group (2006) Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum 54:2665–73
9. Mielants H, Van den Bosch F (2009) Extra-articular manifestations. Clin Exp Rheumatol 27(4 Suppl 55):S56–61
10. Kavanaugh A, Cassell S (2005) The assessment of disease activity and outcomes in psoriatic arthritis. Clin Exp Rheumatol 23:S142–7
11. Peluso R, Di Minno MN, Iervolino S, Manguso F, Tramontano G, Ambrosino P, Esposito C, Scalera A, Castiglione F, Scarpa R (2013) Enteropathic spondyloarthritis: from diagnosis to treatment. Clin Dev Immunol:631408. doi:10.1155/2013/631408
12. Van Praet L, Van den Bosch F, Mielants H, Elewaut D (2011) Mucosal inflammation in spondylarthritides: past, present, and future. Curr Rheumatol Rep 13(5):409–15
13. Fries W (2009) Inflammatory bowel disease-associated spondyloarthropathies. World J Gastroenterol 28;15(20):2441–2
14. Scarpa R, Manguso F, D’Arienzo A, D’Armiento FP, Astarita C, Mazzacca G, Ayala F (2000) Microscopic inflammatory changes in colon of patients with both active psoriasis and psoriatic arthritis without bowel symptoms. J Rheumatol 27(5):1241–6
15. Yates VM, Watkinson G, Kelman A (1982) Further evidence for an association between psoriasis, Crohn’s disease and ulcerative colitis. Br J Dermatol 106:323–30
16. Lee FI, Bellary SV, Francis C (1990) Increased occurrence of psoriasis in patients with Crohn’s disease and their relatives. Am J Gastroenterol 85:962–3
17. Scarpa R, Ayala F, Caporaso N, Olivieri I (2006) Psoriasis, psoriatic arthritis, or psoriatic disease? J Rheumatol 33(2):210–2
18. Li WQ, Han JL, Chan AT, Qureshi AA (2013) Psoriasis, psoriatic arthritis and increased risk of incident Crohn’s disease in US women. Ann Rheum Dis 72(7):1200–5
19. Manguso F, Sanges M, Staiano T, Gargiulo S, Nastro P, Gargano D, Somma P, Mansueto G, Peluso R, Scarpa R, D’Armiento FP, Astarita C, Ayala F, Renda A, Mazzacca G, D’Arienzo A (2004) Cigarette smoking and appendectomy are risk factors for extraintestinal manifestations in ulcerative colitis. Am J Gastroenterol 99(2):327–34
20. Gladman DD (1998) Clinical aspects of the spondyloarthropathies. Am J Med Sci 316:234–238
21. Baldassano VF Jr (1998) Ocular manifestations of rheumatic diseases. Curr Opin Ophthalmol 9:85–88
22. Durrani K, Foster CS (2005) Psoriatic uveitis: a distinct clinical entity? Am J Ophthalmol 139(1):106–11
23. Rosenbaum JT (1992) Acute anterior uveitis and spondyloarthropathies. Rheum Dis Clin N Am 18:143–51
24. Paiva ES, Macaluso DC, Edwards A, Rosenbaum JT (2000) Characterisation of uveitis in patients with psoriatic arthritis. Ann Rheum Dis 59:67–70
25. Queiro R, Torre JC, Belzunegui J, González C, De Dios JR, Unanue F, Figueroa M (2002) Clinical features and predictive factors in psoriatic arthritis-related uveitis. Semin Arthritis Rheum 31(4):264–70
26. Rehal B, Modjtahedi BS, Morse LS, Schwab IR, Maibach HI (2011) Ocular psoriasis. J Am Acad Dermatol 65(6):1202–12
27. Lambert JR, Wright V (1976) Eye inflammation in psoriatic arthritis. Ann Rheum Dis 35(4):354–6
28. Singh G, Kumari N, Aggarwal A, Krishnani N, Misra R (2007) Prevalence of subclinical amyloidosis in ankylosing spondylitis. J Rheumatol 34:371–3
29. El Maghraoui A (2011) Extra-articular manifestations of ankylosing spondylitis: prevalence, characteristics and therapeutic implications. Eur J Int Med 22(6):554–60
30. Wright V, Moll JMH (1976) Psoriatic arthritis. Seronegative polyarthritis. North Holland Publishing, Amsterdam, pp 169–235
31. Gonzalez-Juanatey C, Amigo-Diaz E, Miranda-Filloy JA et al (2006) Lack of echocardiographic and Doppler abnormalities in psoriatic arthritis patients without clinically evident cardiovascular disease or classic atherosclerosis risk factors. Semin Arthritis Rheum 35:333–9
32. Di Minno MN, Iervolino S, Lupoli R, Russolillo A, Coppola A, Peluso R, Scarpa R, Di Minno G (2012) Cardiovascular risk in rheumatic patients: the link between inflammation and atherothrombosis. Semin Thromb Hemost 38(5):497–505
33. Papagoras C, Voulgari PV, Drosos AA (2013) Atherosclerosis and cardiovascular disease in the spondyloarthritides, particularly ankylosing spondylitis and psoriatic arthritis. Clin Exp Rheumatol 31(4):612–20
34. Alhusain A, Bruce IN (2013) Cardiovascular risk and inflammatory rheumatic diseases. Clin Med 13(4):395–7
35. Costa L, Caso F, D’Elia L, Atteno M, Peluso R, Del Puente A, Strazzullo P, Scarpa R (2012) Psoriatic arthritis is associated with increased arterial stiffness in the absence of known cardiovascular risk factors: a case control study. Clin Rheumatol 31(4):711–5
36. Gonzalez-Juanatey C, Llorca J, Amigo-Diaz E, Dierssen T, Martin J, Gonzalez-Gay MA (2007) High prevalence of subclinical atherosclerosis in psoriatic arthritis patients without clinically evident cardiovascular disease or classic atherosclerosis risk factors. Arthritis Rheum 15;57(6):1074–80
37. Sari I, Okan T, Akar S, Cece H, Altay C, Secil M, Birlik M, Onen F, Akkoc N (2006) Impaired endothelial function in patients with ankylosing spondylitis. Rheumatology (Oxford) 45(3):283–6
38. Sampaio-Barros PD, Cerqueira EM, Rezende SM et al (2007) Pulmonary involvement in ankylosing spondylitis. Clin Rheumatol 26:225–30
39. Ko JH, Lin JW, Hui RC (2011) Acute pulmonary embolism in a patient with hypereosinophilia and psoriasis. Chang Gung Med J 34(6 Suppl):17–23
40. Manuel A, Jones Q, Wiggins J (2010) Multiple pulmonary nodules in a male with psoriatic arthritis. Eur Respir Rev 19(116):164–5
41. Angulo J, Espinoza LR (1998) The spectrum of skin, mucosa and other extra-articular manifestations. Baillieres Clin Rheumatol 12(4):649–64
42. Manguso F, Staiano T, Astarita C, Scarpa R, Peluso R, Gargano D, Ayala F, D’Arienzo A (2005) Consecutive occurrence of rhinoconjunctivitis, seronegative spondyloarthritis and pyoderma gangrenosum in a patient with ulcerative colitis. Int J Color Dis 20(1):79–80
43. Yamamoto T, Yokozeki H, Nishioka K (2005) Clinical analysis of 21 patients with psoriasis arthropathy. J Dermatol 32:84–90
44. Tan ES, Chong WS, Tey HL (2012) Nail psoriasis: a review. Am J Clin Dermatol 13(6):375–88
45. Scarpa R, Oriente P, Pucino A et al (1994) Psoriatic arthritis in psoriatic patients. Br J Rheumatol 23:246–250
46. Scarpa R, Manguso F, Oriente A, Peluso R, Atteno M, Oriente P (2004) Is the involvement of the distal interphalangeal joint in psoriatic patients related to nail psoriasis? Clin Rheumatol 23(1):27–30
47. Jones SM, Armas JB, Cohen MG, Lovell CR, Evison G, McHugh NJ (1994) Psoriatic arthritis: outcome of disease subsets and relationship of joint disease to nail and skin disease. Br J Rheumatol 33:834–839
48. Soscia E, Scarpa R, Cimmino MA, Atteno M, Peluso R, Sirignano C, Costa L, Iervolino S, Caso F, Del Puente A, Salvatore M, Soricelli A (2009) Magnetic resonance imaging of nail unit in psoriatic arthritis. J Rheumatol Suppl 83:42–5
49. Soscia E, Sirignano C, Catalano O, Atteno M, Costa L, Caso F, Peluso R, Bruner V, Aquino MM, Del Puente A, Salvatore M, Scarpa R (2012) New developments in magnetic resonance imaging of the nail unit. J Rheumatol Suppl 89:49–53
50. Scarpa R, Soscia E, Peluso R, Atteno M, Manguso F, Del Puente A, Spanò A, Sirignano C, Oriente A, Di Minno MN, Iervolino S, Salvatore M (2006) Nail and distal interphalangeal joint in psoriatic arthritis. J Rheumatol 33(7):1315–9